Generation bio reports business highlights and first quarter 2023 financial results

Company entered into strategic collaboration with moderna to use generation bio's proprietary non-viral genetic medicine delivery system for two liver disease programs and to co-develop novel targeting for immune cells

GBIO Ratings Summary

GBIO Quant Ranking